ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Anika Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$20.22+0.24 (+1.20%)
Close on Oct 19, 2026
- Market cap
- $277.36M
- P/E (TTM)
- –
- Dividend yield
- –
Anika Therapeutics, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OEM Channel [Member] | $18.71M | $17.04M | $17.31M | $15.84M | $16.34M | $14.91M | $19.67M | $19.76M | $18.89M | $19.45M | – | – | 57.4% | +14.5% |
| Commercial Channel [Member] | $13.91M | $12.58M | $13.30M | $11.97M | $11.88M | $11.26M | $10.93M | $9.80M | $11.84M | $9.57M | – | – | 42.6% | +17.1% |
| Joint Preservation and Restoration [Member] | – | – | – | – | – | – | – | $11.95M | $13.55M | $13.84M | $15.30M | $13.47M | – | – |
| Non-Orthopedic [Member] | – | – | – | – | – | – | – | $2.38M | $1.71M | $2.36M | $2.60M | $3.11M | – | – |
| OA Pain Management [member] | – | – | – | – | – | – | – | $24.43M | $26.66M | $24.32M | $25.07M | $24.89M | – | – |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $19.80M | $18.53M | $18.33M | $17.45M | $17.92M | $16.36M | $21.40M | $20.59M | $20.09M | $20.37M | $32.14M | $30.83M | 60.7% | +10.5% |
| Europe [Member] | $6.84M | $6.67M | $6.00M | $5.67M | $4.75M | $5.80M | $4.33M | $4.80M | $5.71M | $4.57M | $556.00K | $5.42M | 21.0% | +43.9% |
| Other Location [Member] | $5.97M | $4.41M | $6.29M | $4.70M | $5.54M | $4.01M | $4.88M | $4.18M | $4.92M | $4.09M | $620.00K | $5.21M | 18.3% | +7.7% |
From the segment and revenue-disaggregation notes of Anika Therapeutics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.